| Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery (NCT00041275) | National Medical Research Council (NMRC), Singapore | 2002-05-01 |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (NCT00310115) | M.D. Anderson Cancer Center | 2002-04-01 |
| National Registry and Blood Bank of Patients With Liver Cancer (NCT00482365) | Vanderbilt-Ingram Cancer Center | 2002-04-01 |
| ABT-751 in Treating Young Patients With Refractory Solid Tumors (NCT00036959) | National Institutes of Health Clinical Center (CC) | 2002-03-01 |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer (NCT00027534) | Michael Morse, MD | 2002-01-01 |
| Epirubicin and Thalidomide in Treating Patients With Liver Cancer (NCT00058487) | Dana-Farber Cancer Institute | 2001-12-01 |
| Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy (NCT00030108) | National Institutes of Health Clinical Center (CC) | 2001-11-01 |
| Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer (NCT00030511) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-10-01 |
| Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer (NCT00006010) | Alliance for Clinical Trials in Oncology | 2001-09-01 |
| Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor (NCT00021047) | National Institutes of Health Clinical Center (CC) | 2001-07-01 |
| Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer (NCT00030082) | National Cancer Institute (NCI) | 2001-07-01 |
| Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer (NCT00027768) | National Medical Research Council (NMRC), Singapore | 2001-06-01 |
| Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer (NCT00009893) | Alliance for Clinical Trials in Oncology | 2001-05-01 |
| TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) (NCT00077142) | M.D. Anderson Cancer Center | 2001-04-01 |
| Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors (NCT00024258) | Memorial Sloan Kettering Cancer Center | 2001-03-01 |
| Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma (NCT06146127) | Inserm U955 | 2001-01-15 |
| Vaccine Therapy in Treating Patients With Liver Cancer (NCT00022334) | Jonsson Comprehensive Cancer Center | 2001-01-01 |
| Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed (NCT00040898) | Memorial Sloan Kettering Cancer Center | 2001-01-01 |
| Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer (NCT00012324) | Eximias Pharmaceutical | 2000-09-01 |
| Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed (NCT00006006) | National Cancer Institute (NCI) | 2000-08-01 |
| Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery (NCT00039078) | Allan Tsung | 2000-08-01 |
| Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors (NCT00020150) | National Cancer Institute (NCI) | 2000-06-01 |
| UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer (NCT00900094) | University of Michigan Rogel Cancer Center | 2000-06-01 |
| Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract (NCT00582647) | Memorial Sloan Kettering Cancer Center | 2000-03-01 |
| DX-8951f in Treating Patients With Biliary Cancer (NCT00005938) | Daiichi Sankyo | 2000-03-01 |
| Recurrence of Liver Malignancy After Ischemia/Reperfusion Injury (NCT04257240) | Aretaieion University Hospital | 2000-01-01 |
| Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver (NCT00003907) | Eastern Cooperative Oncology Group | 1999-12-15 |
| DX-8951f in Treating Patients With Liver Cancer (NCT00004108) | Daiichi Sankyo | 1999-09-01 |
| Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases (NCT00019786) | National Institutes of Health Clinical Center (CC) | 1999-08-01 |
| Vaccine Therapy in Treating Patients With Liver Cancer (NCT00005629) | Jonsson Comprehensive Cancer Center | 1999-07-01 |
| Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT00004248) | Roswell Park Cancer Institute | 1999-07-01 |
| Microarray Analysis of Gene Expression in Liver Tumors (NCT00373737) | Stanford University | 1999-05-01 |
| Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer (NCT00005997) | Case Comprehensive Cancer Center | 1999-04-01 |
| Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas (NCT00003923) | Memorial Sloan Kettering Cancer Center | 1999-03-01 |
| Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer (NCT00003557) | University of Chicago | 1999-01-01 |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors (NCT00003926) | Masonic Cancer Center, University of Minnesota | 1998-11-01 |
| Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer (NCT00019604) | National Institutes of Health Clinical Center (CC) | 1998-08-01 |
| Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas (NCT00019513) | National Institutes of Health Clinical Center (CC) | 1998-08-01 |
| Chemotherapy in Treating Children With Liver Cancer (NCT00003912) | Societe Internationale d'Oncologie Pediatrique | 1998-06-01 |
| Proton Beam Therapy for Treatment of Hepatocellular Carcinoma (NCT00614913) | Loma Linda University | 1998-05-01 |
| Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer (NCT00004136) | M.D. Anderson Cancer Center | 1998-03-09 |
| Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer (NCT00019474) | Montefiore Medical Center | 1998-03-01 |
| Gene Therapy in Treating Patients With Cancer of The Liver (NCT00003147) | National Cancer Institute (NCI) | 1998-02-01 |
| Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer (NCT00003296) | Brown University | 1998-01-01 |
| Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors (NCT00019331) | National Cancer Institute (NCI) | 1997-10-01 |
| Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors (NCT00007813) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1997-05-31 |
| Tamoxifen in Treating Patients With Primary Liver Cancer (NCT00003424) | National Medical Research Council (NMRC), Singapore | 1997-04-01 |
| Biological Therapy in Treating Patients With Metastatic Cancer (NCT00004604) | Duke University | 1997-02-01 |
| Spectroscopy With Surface Coils and Decoupling (NCT00581815) | Memorial Sloan Kettering Cancer Center | 1997-02-01 |
| Chemotherapy in Treating Patients With Liver Cancer (NCT00003044) | Matrix Pharmaceutical | 1996-09-01 |
| Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases (NCT00002655) | University of Colorado, Denver | 1995-03-01 |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors (NCT00002608) | Ottawa Regional Cancer Centre | 1994-05-01 |
| Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer (NCT00002515) | Memorial Sloan Kettering Cancer Center | 1992-10-01 |
| Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer (NCT00002485) | Children's Oncology Group | 1992-02-01 |
| TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma (NCT00906984) | University of California, Irvine | |
| Therasphere for Unresectable Primary or Secondary Liver Neoplasia (NCT02960620) | H. Lee Moffitt Cancer Center and Research Institute | |
| A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma (NCT01076517) | Stanford University | |
| Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer (NCT00093548) | Jonsson Comprehensive Cancer Center | |
| Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer (NCT00006198) | National Center for Research Resources (NCRR) | |